Tag: Ruxolitinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ruxolitinib

FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older

Added to Collection on: 2022-07-19 18:06:24

Tags for this article:

Chemical compounds

Autoimmune diseases

Vitiligo

Biology

Organ systems

Janus kinase inhibitor

Click the tags to see associated articles and topics

View Article Details

Role of JAK Inhibitors in Vitiligo Treatment - Managed Healthcare Executive

Added to Collection on: 2022-10-01 04:55:51

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Rampal Reviews Data for First-line Therapy in Myelofibrosis With High Platelet Count

Added to Collection on: 2022-11-13 00:10:09

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Opna Bio Launches With $38M Series A Financing | Precision Oncology News

Added to Collection on: 2022-11-23 07:09:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study ...

Added to Collection on: 2022-12-10 23:13:53

Tags for this article:

Janus kinase inhibitor

Janus kinase 2

Oncology

Sumitomo Pharma Oncology Inc.

Click the tags to see associated articles and topics

View Article Details

Incyte shares drop after FDA approves GSK's competing blood-cancer treatment

Added to Collection on: 2023-09-18 12:17:49

Tags for this article:

Financial data vendors

Primary myelofibrosis

The Wall Street Journal

Incyte Corp

Click the tags to see associated articles and topics

View Article Details

Conference Recap: 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema

Added to Collection on: 2024-06-11 23:48:23

Tags for this article:

Autoimmune diseases

Type I hypersensitivity

Click the tags to see associated articles and topics

View Article Details

Leqselvi Approved for Severe Alopecia Areata - MPR - eMPR.com

Added to Collection on: 2024-07-26 16:13:43

Tags for this article:

Disease-modifying antirheumatic drugs

Click the tags to see associated articles and topics

View Article Details

Atopic Dermatitis Treatment: Past, Present and Future - Managed Healthcare Executive

Added to Collection on: 2024-08-04 18:47:57

Tags for this article:

Type I hypersensitivity

Autoimmune diseases

Atopic dermatitis

Dermatitis

Janus kinase inhibitor

Click the tags to see associated articles and topics

View Article Details

Abemaciclib + Elacestrant for ER+/HER2– MBC: Pooled Data Analysis Presented at SABCS 2024

Added to Collection on: 2024-12-25 13:51:54

Tags for this article:

Transplantation medicine

Graft-versus-host disease

Stephanie Lee

Chronic condition

Click the tags to see associated articles and topics

View Article Details

Tag: Ruxolitinib

Recent Related Articles to Ruxolitinib

FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older

Role of JAK Inhibitors in Vitiligo Treatment - Managed Healthcare Executive

Rampal Reviews Data for First-line Therapy in Myelofibrosis With High Platelet Count

Opna Bio Launches With $38M Series A Financing | Precision Oncology News

Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study ...

Incyte shares drop after FDA approves GSK's competing blood-cancer treatment

Conference Recap: 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema

Leqselvi Approved for Severe Alopecia Areata - MPR - eMPR.com

Atopic Dermatitis Treatment: Past, Present and Future - Managed Healthcare Executive

Abemaciclib + Elacestrant for ER+/HER2– MBC: Pooled Data Analysis Presented at SABCS 2024

Create dashboard for Tag: Ruxolitinib